Gerard P. Zambetti, PhD

Gerard P. Zambetti, PhD

Member, St. Jude Faculty
Vice President and Director of Academic Programs in Biomedical Sciences
Associate Director for Training and Education, Cancer Center

Departments

Biochemistry

Contact Information

Gerard Zambetti, PhD
Biochemistry
MS 340 Room D4063C
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: gerard.zambetti@stjude.org
Phone: (901) 595-3429
FAX: (901) 525-8025

Education

MS - Emory University, Atlanta, Georgia
PhD - University of Florida, Gainesville


Research Interests

  • Function of wild-type and mutant p53 in tumor suppression and oncogenesis
  • Regulation of cell cycle, cell survival and differentiation

Function of p53 in tumor suppression and tumorigenesis


Selected Publications

Steimer DA, Boyd K, Takeuchi O, Fisher JK, Zambetti GP, Opferman JT. Selective roles for anti-apoptotic MCL-1 during granulocyte development and macrophage effector function. Blood 2009 (in press).

Russell-Swetek A, West AN, Mintern JE, Jenkins J, Rodriguez-Galindo C, Ribeiro R, Zambetti GP. Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma. J Med Genet 45:603-606, 2008.

Assumpção JG, Seidinger AL, Mastellaro MJ, Ribeiro RC, Zambetti GP, Ganti R, Srivastava K, Shurtleff S, Pei D, Zeferino LC, Dufloth RM, Brandalise SR, Yunes JA. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 8:357, 2008.

Garrison SP, Jeffers JR, Yang C, Nilsson JA, Rehg J, Yue W, Yu J, Zhang L, Sample JT, Cleveland JL, Zambetti GP. Selection against PUMA gene expression in Myc-driven B cell lymphomagenesis. Mol Cell Biol 28:5391-5402, 2008 (featured in Nature Reviews of Cancer 8:568-569, 2008).

Qui W, Carson-Walter EB, Liu H, Epperly M, Greenberger JS, Zambetti GP, Zhang L, Yu J. The BH3-only Protein PUMA regulates intestinal stem cell radiosensitivity. Cell Stem Cell 2:576-583, 2008 (see Preview Cell Stem Cell 2: 517-518, 2008).

Rosati R, Cerrato F, Doghman M, Pianovski M, Parise GA, Custódio G, Zambetti GP, Riccio A, Ribeiro RC, Figueiredo BC, Lalli E. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression is not associated with clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation. Cancer Genet Cytogenet 186: 19-24, 2008.

Zambetti GP. The p53 mutation “Gradient Effect” and its clinical implications. J Cell Phys 213:370-373, 2007.

Doghman M, Karpova T, Rodrigues G, Arhatte M, De Moura J, Cavalli LR, Virolle V, Barbry P, Zambetti GP, Figueiredo BC, Heckert LL, Lalli E. Increased Steroidogenic Factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endo 21:2968-2987, 2007.

Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, Grosso S, Laurent M, Mas JC, Bongain A, Zambetti GP, Figueiredo BC, Auberger P, Martinerie C, Lalli E. NOV/CCN3 is a selective pro-apoptotic factor for adrenocortical cells downregulated in childhood adrenocortical tumors. J Clin Endo Metab 92:3253-3260, 2007.

Ribeiro R, Figueiredo BC, Rodriguez-Galindo C, Mastellaro MJ, West AN, Kriwacki R, Zambetti GP. Germline TP53 R337H mutation is not sufficient to determine Li-Fraumeni or Li-Fraumeni-like syndrome. Can Lett 247:353-355, 2007.

West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA, Oliveira Filho AG, Malkin D, Lalli E, Ribeiro R, Zambetti GP. Gene Expression Profiling of Childhood Adrenocortical Tumors. Cancer Res 67:600-608, 2007.

Wu B, Qiu W, Wang P, Yue W, Yu H, Cheng T, Zambetti GP, Zhang L, Yu J. PUMA is a mediator of p53-independent intestinal apoptosis induced by ischemia reperfusion. Gut 56:645-54, 2007.

Broniscer A, Baker SJ, West AN, Fraser MM, Kocak M, Dalton J, Zambetti GP, Gajjar A, Gilbertson RJ, Fuller CE Clinical and molecular characteristics of malignant transformation of low-grade glioma in children: the St. Jude Children’s Research Hospital experience. J Clin Oncol 25:682-689, 2007.

Pianovski MA, Cavalli LR, Figueiredo BC, Santos SC, Doghman M,Ribeiro RC, Michalkiewicz E, Zambetti GP, Haddad BR, Lalli E. SF-1 Overexpression in Childhood Adrenocortical Tumors. Int J Cancer 42:1040-1043, 2006.

Zambetti GP, Horwitz EM, Schipani E. Skeletons in the p53 tumor suppressor closet: Genetic evidence that p53 blocks bone differentiation and development. J Cell Biol 172:795-797, 2006.

Kim H, Tu HC, Rafiuddin-Shah M, Jeffers JR, Zambetti GP, Hsieh J, Cheng EHY. Hierarchical Regulation of Mitochondrion-Dependent Apoptosis by BCL-2 Subfamilies. Nat Cell Biol 8: 1348-1358, 2006 (see News & Views, Nat Cell Biol 8: 1317-1319).

Opferman JT, Zambetti GP. Translational Research? Ribosome integrity and a new p53 tumor suppressor checkpoint. Cell Death Diff 13:898-901, 2006.

West AN, Ribeiro RC, Jenkins J, Rodriguez-Galindo C, Figueiredo BC, Kriwacki R, Zambetti GP. Identification of a Novel Germline Variant Hotspot Mutant p53-R175L in Pediatric Adrenal Cortical Carcinoma. Can Res 66:5056-5062, 2006.

Toth A, Jeffers JR, Nickson P, Min JY, Morgan JP, Zambetti GP, Erhardt P. Targeted Deletion of Puma Attenuates Cardiomyocyte Death and Improves Cardiac Function during Ischemia/reperfusion. Am J Physiol Heart Circ Physiol 291: 52-60, 2006 (see Editorial Focus).

Figueiredo BC, Sandrini R, Zambetti GP, Pereira RM, Cheng C, Lacerda L, Pianovski MA, Michalkiewicz E, Jenkins J, Rodriguez-Galindo C, Mastellaro MJ, Vianna S, Sandrini F, Arram SIB, Ribeiro RC. Penetrance of Adrenocortical Tumors Associated with the Germline TP53 R337H Mutation. J Med Genet 43: 91-96, 2006.

Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, Look AT. Slug Antagonizes p53-Mediated Apoptosis of Hematopoietic Progenitors by Repressing Puma. Cell 123: 641-653, 2005. (Cover, see Previews).

Lozano G, Zambetti GP. Gankyrin: An intriguing name for a novel regulator of p53 and RB. Cancer Cell 8:3-4, 2005.

Myers MC, Wang J, Zambetti GP, Appella DH. Targeting mutant p53 using a new family of small molecules derived from serine. J Am Chem Soc 127:6152-6153, 2005.

Lozano G, Zambetti GP. What have animal models taught us about the p53 pathway? J Path 205:206-220, 2005.

Figueiredo BC, Cavalli LR, Pianovski MA, Lalli E, Sandrini R, Ribeiro RC, Zambetti GP, DeLacerda L, Rodrigues GA, Haddad BR. Amplification of the steroidogenic factor 1 (SF-1) gene in childhood adrenocortical tumors. J Clin Endo Metab 90:615-619, 2005.

Rodriguez-Galindo C, de Figueiredo BC, Zambetti GP, Ribeiro RC. Biology, clinical characteristics and management of adrenocortical tumors in children. Pediatric Blood & Cancer 44: 1-9, 2005.

Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell: 4: 321-328, 2003. (see Previews, Cancer Cell 4: 248-249).

Lee AS, Galea C, DiGiammarino EL, Jun B, Murti G, Ribeiro RC, Zambetti GP, Schultz CP, Kriwacki RW. Structural polymorphism of the p53 tetramerization domain. J Mol Biol 327: 699-709, 2003.

Weber JD, Zambetti GP. Renewing the Debate Over the p53 Apoptotic Response. Cell Death Diff 10: 409-412, 2003.

Zambetti GP, Kastan MB. Overcoming p53 Parking Problems. Cell 112:1-2, 2003.

DiGiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, Ribeiro RC, Zambetti GP, Kriwacki RW. Evidence for a novel molecular mechanism of tumorigenesis: pH-dependent destabilization of the p53 tetramer. Nat Struct Biol 9:12-16, 2002. (News & Views, Nat Med 8: 21-23, 2002).

DiGiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, Ribeiro RC, Zambetti G, Kriwacki RW. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 9 (1):12-16, 2002.

Last update: February 2009

Email This Article Email This Article   |   Print Print